Jefferies Group LLC Adma Biologics, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.89 - $5.15 $1.95 Million - $2.58 Million	-500,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$3.19 - $5.39 $845,350 - $1.43 Million	-265,000 Reduced 34.64%	500,000 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $2.69 Million - $4.01 Million	765,000 New	765,000 $2.96 Million
Q2 2018 Aug 14, 2018	SELL	$4.39 - $5.44 $82,971 - $102,816	-18,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.21 - $5.21 $60,669 - $98,469	18,900 New	18,900 $87,000

317

189M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.23B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.